Fukoku Mutual Life Insurance CO Alnylam Pharmaceuticals, Inc. Transaction History
Fukoku Mutual Life Insurance CO
- $1.36 Billion
- Q4 2024
A detailed history of Fukoku Mutual Life Insurance CO transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Fukoku Mutual Life Insurance CO holds 914 shares of ALNY stock, worth $222,586. This represents 0.02% of its overall portfolio holdings.
Number of Shares
914
Previous 914
-0.0%
Holding current value
$222,586
Previous $251,000
14.34%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding ALNY
# of Institutions
670Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.04 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.1 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.33 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.7 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.07 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...